ID   IGRMel1
AC   CVCL_B4KT
SY   Institut Gustave Roussy Melanoma 1
DR   cancercelllines; CVCL_B4KT
DR   Wikidata; Q110432920
RX   PubMed=27533468;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=27533468).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=27533468; DOI=10.1080/15384101.2016.1208862; PMCID=PMC5026796;
RA   Malka-Mahieu H., Girault I., Rubington M., Leriche M., Welsch C.,
RA   Kamsu-Kom N., Zhao Q., Desaubry L., Vagner S., Robert C.;
RT   "Synergistic effects of eIF4A and MEK inhibitors on proliferation of
RT   NRAS-mutant melanoma cell lines.";
RL   Cell Cycle 15:2405-2409(2016).
//